The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Burrell Terry-ann since 2020.
This trader's CIK number is 1786484.
At the time of last reporting, Burrell Terry-ann was the Chief Financial Officer of Beam Therapeutics Inc.. (stock ticker symbol BEAM).
Also see all insider trading activities at Beam Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | BEAM | 0 | $0 | 5,446 | $174,925 | 0 | $0 |
| 2023 | BEAM | 0 | $0 | 109,325 | $4,858,800 | 97,376 | $1,332,101 |
| 2022 | BEAM | 0 | $0 | 1,787 | $105,629 | 0 | $0 |
| 2021 | BEAM | 0 | $0 | 55,000 | $5,689,475 | 55,000 | $752,400 |
| 2020 | BEAM | 0 | $0 | 0 | $0 | 7,309 | $99,987 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | RXRX | 0 | $0 | 117,000 | $1,481,250 | 0 | $0 |
1. Beam Therapeutics Inc. (BEAM)
2. Recursion Pharmaceuticals, Inc. (RXRX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-04-01 | BEAM | Sale | 5,446 | 32.12 | 174,925 |
| 2023-04-03 | BEAM | Sale | 2,454 | 30.31 | 74,380 |
| 2023-04-04 | BEAM | Sale | 2,186 | 29.09 | 63,597 |
| 2023-01-27 | BEAM | Sale | 36,152 | 45.08 | 1,629,732 |
| 2023-01-26 | BEAM | Sale | 1,102 | 45.16 | 49,763 |
| 2023-01-27 | BEAM | Option Ex | 36,152 | 13.68 | 494,559 |
| 2023-01-26 | BEAM | Option Ex | 1,102 | 13.68 | 15,075 |
| 2023-01-23 | BEAM | Sale | 5,426 | 45.02 | 244,289 |
| 2023-01-24 | BEAM | Sale | 14,810 | 45.01 | 666,657 |
| 2023-01-23 | BEAM | Option Ex | 5,426 | 13.68 | 74,227 |
| 2023-01-24 | BEAM | Option Ex | 14,810 | 13.68 | 202,600 |
| 2023-01-18 | BEAM | Option Ex | 39,886 | 13.68 | 545,640 |
| 2023-01-18 | BEAM | Sale | 47,195 | 45.14 | 2,130,382 |
| 2022-03-31 | BEAM | Sale | 1,787 | 59.11 | 105,629 |
| 2021-06-30 | BEAM | Sale | 30,000 | 122.00 | 3,660,000 |
| 2021-06-30 | BEAM | Option Ex | 30,000 | 13.68 | 410,400 |
| 2021-01-04 | BEAM | Option Ex | 25,000 | 13.68 | 342,000 |
| 2021-01-04 | BEAM | Sale | 25,000 | 81.18 | 2,029,475 |
| 2020-09-18 | BEAM | Option Ex | 7,309 | 13.68 | 99,987 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-07-12 | RXRX | Sale | 108,725 | 12.67 | 1,377,110 |
| 2023-07-13 | RXRX | Sale | 8,275 | 12.59 | 104,140 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Burrell Terry-ann (Chief Financial Officer of Beam Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.